4.7 Article

Further Developments towards a Minimal Potent Derivative of Human Relaxin-2

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, Research & Experimental

The single-chain relaxin mimetic, B7-33, maintains the cardioprotective effects of relaxin and more rapidly reduces left ventricular fibrosis compared to perindopril in an experimental model of cardiomyopathy

Fariha Alam et al.

Summary: This study found that B7-33 can retain the cardioprotective effects of RLX and has a better therapeutic effect compared to the ACE inhibitor perindopril. Therefore, B7-33 could be considered as a cost-effective cardioprotective therapy.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Article Biochemistry & Molecular Biology

A Lipidated Single-B-Chain Derivative of Relaxin Exhibits Improved In Vitro Serum Stability without Altering Activity

Praveen Praveen et al.

Summary: Human relaxin-2 (H2 relaxin) has therapeutic importance due to its anti-fibrotic, vasodilatory, and cardioprotective effects. Relaxin family peptide receptor 1 (RXFP1), the receptor for relaxin, is a potential target for treating fibrosis and related disorders. A single-chain agonist, B7-33 peptide, has been developed based on the B-chain of H2 relaxin but has a short circulation time in vitro.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Pharmacology & Pharmacy

Challenges for Clinical Drug Development in Pulmonary Fibrosis

Eric S. White et al.

Summary: Pulmonary fibrosis is a pathologic process associated with scarring of the lung interstitium. Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic interstitial lung disease (ILD) characterized by respiratory failure and death. The development of pirfenidone and nintedanib has been a major breakthrough in the treatment of IPF, but there is still no cure for pulmonary fibrosis. Future treatment of pulmonary fibrosis may require more precision in targeting specific cell populations and exploring novel measures of efficacy.

FRONTIERS IN PHARMACOLOGY (2022)

Article Multidisciplinary Sciences

Characterization of a new potent and long-lasting single chain peptide agonist of RXFP1 in cells and in vivo translational models

Stephane Illiano et al.

Summary: A new long-lasting RXFP1 agonist, SA10SC-RLX, has been developed and shown to mimic the activity of relaxin. It can be administered subcutaneously and has potential for treating chronic fibrotic and cardiovascular diseases.

SCIENTIFIC REPORTS (2022)

Article Pharmacology & Pharmacy

Synthetic short-chain peptide analogues of H1 relaxin lack affinity for the RXFP1 receptor and relaxin-like bioactivity. Clues to a better understanding of relaxin agonist design

Annunziata D'Ercole et al.

Summary: This study synthesized and tested a set of low molecular weight peptides in order to obtain RLX analogues with improved pharmacokinetic features. However, none of these peptides showed sufficient affinity to the specific RLX receptor RXFP1 or RLX-like biological effects.

FRONTIERS IN PHARMACOLOGY (2022)

Article Chemistry, Medicinal

Identification of Potent and Long-Acting Single-Chain Peptide Mimetics of Human Relaxin-2 for Cardiovascular Diseases

Sergio Mallart et al.

Summary: This study involves the development of long-acting potent single-chain relaxin peptide mimetics by modifying the B-chain of relaxin, introducing specific mutations and trimming the sequence to an optimal size. These modifications resulted in potent, structurally simplified peptide agonists of the relaxin receptor RXFP1, with high subcutaneous bioavailability and extended half-lives, showing in vivo efficacy.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Cardiac & Cardiovascular Systems

B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice

Teja Devarakonda et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)

Review Multidisciplinary Sciences

Fibrosis: from mechanisms to medicines

Neil C. Henderson et al.

NATURE (2020)

Article Nanoscience & Nanotechnology

Coatings Releasing the Relaxin Peptide Analogue B7-33 Reduce Fibrotic Encapsulation

Nicholas G. Welch et al.

ACS APPLIED MATERIALS & INTERFACES (2019)

Review Biochemistry & Molecular Biology

Challenges in the design of insulin and relaxin/insulin-like peptide mimetics

Mohammed Akhter Hossain et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2018)

Review Pharmacology & Pharmacy

Relaxin as a Therapeutic Target for the Cardiovascular Complications of Diabetes

Hooi Hooi Ng et al.

FRONTIERS IN PHARMACOLOGY (2018)

Review Pharmacology & Pharmacy

Anti-fibrotic actions of relaxin

C. S. Samuel et al.

BRITISH JOURNAL OF PHARMACOLOGY (2017)

Review Pharmacology & Pharmacy

Vascular actions of relaxin: nitric oxide and beyond

C. H. Leo et al.

BRITISH JOURNAL OF PHARMACOLOGY (2017)

Article Pharmacology & Pharmacy

B7-33 replicates the vasoprotective functions of human relaxin-2 (serelaxin)

Sarah A. Marshall et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2017)

Review Pharmacology & Pharmacy

Relaxin family peptides: structure-activity relationship studies

Nitin A. Patil et al.

BRITISH JOURNAL OF PHARMACOLOGY (2017)

Article Chemistry, Medicinal

Development of a Single-Chain Peptide Agonist of the Relaxin-3 Receptor Using Hydrocarbon Stapling

Keiko Hojo et al.

JOURNAL OF MEDICINAL CHEMISTRY (2016)

Meeting Abstract Biochemistry & Molecular Biology

SINGLE-CHAIN DERIVATIVE OF THE RELAXIN HORMONE IS A FUNCTIONALLY SELECTIVE AGONIST OF THE G PROTEIN-COUPLED RECEPTOR,RXFP1

M. A. Hossain et al.

JOURNAL OF PEPTIDE SCIENCE (2016)

Review Physiology

RELAXIN FAMILY PEPTIDES AND THEIR RECEPTORS

R. A. D. Bathgate et al.

PHYSIOLOGICAL REVIEWS (2013)

Article Endocrinology & Metabolism

The Different Ligand-Binding Modes of Relaxin Family Peptide Receptors RXFP1 and RXFP2

Daniel J. Scott et al.

MOLECULAR ENDOCRINOLOGY (2012)

Article Cardiac & Cardiovascular Systems

Relaxin, a pleiotropic vasodilator for the treatment of heart failure

Sam L. Teichman et al.

HEART FAILURE REVIEWS (2009)

Article Cardiac & Cardiovascular Systems

The pathophysiology of acute heart failure - Is it all about fluid accumulation?

Gad Cotter et al.

AMERICAN HEART JOURNAL (2008)

Review Cardiac & Cardiovascular Systems

Acute heart failure as acute endothelitis - Interaction of fluid overload and endothelial dysfunction

Paolo C. Colombo et al.

EUROPEAN JOURNAL OF HEART FAILURE (2008)

Article Biochemical Research Methods

Using circular dichroism spectra to estimate protein secondary structure

Norma J. Greenfield

NATURE PROTOCOLS (2006)

Article Biochemistry & Molecular Biology

Peptide helices based on alpha-amino acids

M Crisma et al.

BIOPOLYMERS (2006)

Article Cardiac & Cardiovascular Systems

Cell signalling in the cardiovascular system: an overview

CPD Wheeler-Jones

Review Chemistry, Multidisciplinary

Single turn peptide alpha helices with exceptional stability in water

NE Shepherd et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)

Article Multidisciplinary Sciences

Activation of orphan receptors by the hormone relaxin

SY Hsu et al.

SCIENCE (2002)